PubMed:23811795 / 0-113
Annnotations
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":113},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":113},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":113},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation."}
GlycoBiology-FMA
{"project":"GlycoBiology-FMA","denotations":[{"id":"_T1","span":{"begin":51,"end":56},"obj":"FMAID:68646"},{"id":"_T2","span":{"begin":51,"end":56},"obj":"FMAID:169002"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation."}
uniprot-human
{"project":"uniprot-human","denotations":[{"id":"T1","span":{"begin":0,"end":31},"obj":"http://www.uniprot.org/uniprot/Q06430"},{"id":"T3","span":{"begin":0,"end":31},"obj":"http://www.uniprot.org/uniprot/Q8N0V5"},{"id":"T5","span":{"begin":0,"end":31},"obj":"http://www.uniprot.org/uniprot/Q8NFS9"},{"id":"T7","span":{"begin":92,"end":96},"obj":"http://www.uniprot.org/uniprot/Q9GZX1"},{"id":"T13","span":{"begin":97,"end":101},"obj":"http://www.uniprot.org/uniprot/Q16512"},{"id":"T22","span":{"begin":97,"end":101},"obj":"http://www.uniprot.org/uniprot/Q13153"}],"text":"N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation."}
uniprot-mouse
{"project":"uniprot-mouse","denotations":[{"id":"T1","span":{"begin":0,"end":31},"obj":"http://www.uniprot.org/uniprot/P97402"}],"text":"N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation."}
GlycoBiology-NCBITAXON
{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T1","span":{"begin":51,"end":56},"obj":"http://purl.bioontology.org/ontology/STY/T025"}],"text":"N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation."}
GO-BP
{"project":"GO-BP","denotations":[{"id":"T1","span":{"begin":0,"end":33},"obj":"http://purl.obolibrary.org/obo/GO_0030144"},{"id":"T3","span":{"begin":76,"end":83},"obj":"http://purl.obolibrary.org/obo/GO_0043276"},{"id":"T9","span":{"begin":92,"end":96},"obj":"http://purl.obolibrary.org/obo/GO_0005006"}],"text":"N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation."}
GO-CC
{"project":"GO-CC","denotations":[{"id":"T1","span":{"begin":51,"end":56},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation."}
mondo_disease
{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":42,"end":50},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0007256"}],"text":"N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation."}